Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases
NCT01470105 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 230
Last updated 2026-01-07
Summary
The goal of this study is to improve how we estimate survival of people with cancer that has spread to their bone. There have been previous attempts to estimate survival of people with cancer that spread to the bone, but they have not been accurate. This study will try to improve the way we estimate survival in people with cancer that has spread to their bone by looking to see if a physician assessment and a patient assessment of the health status can be blended to give a better estimate of survival than patients or doctors alone.
Conditions
Interventions
- OTHER
-
blood sampling, the SF-36 questionnaire
The patient be asked to fill out a questionnaire. The questionnaire asks about their quality of life and will take approximately 15 minutes to complete. It will be completed at a regularly scheduled clinic visit. At the scheduled pre-operative testing, an extra sample of your blood (equal to about 4 teaspoons) will be collected for research tests. The research tests will measure levels of inflammation in your body. These tests are not part of routine care. A physical examination of the operative site will be done by the Orthopaedic Surgeon. The patient will complete the same questionnaire at the regularly scheduled three and six month follow-up visit
Sponsors & Collaborators
-
Montefiore Medical Center
collaborator OTHER -
Memorial Sloan Kettering Cancer Center
lead OTHER
Principal Investigators
-
Carol Morris, MD · Memorial Sloan Kettering Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-11-30
- Primary Completion
- 2026-11-30
- Completion
- 2026-11-30
Countries
- United States
Study Locations
More Related Trials
-
Intensive Combo Chemo With Autologous BM Rescue for Metastatic Breast Cancer
NCT00584766 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Older Women With Metastatic Breast Cancer
NCT00010075 ·Status: UNKNOWN ·Phase: PHASE2
-
High Dose Chemo With Autologous BMT for Treatment of Metastatic Breast Cancer
NCT00584428 ·Status: COMPLETED ·Phase: NA
-
Metabolomics Explores Biomarkers for Metastatic Breast Cancer
NCT04302415 ·Status: UNKNOWN
-
Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis
NCT03691493 ·Status: COMPLETED ·Phase: PHASE2
-
BP-C1 Monotherapy in Patients With Metastatic Breast Cancer Cancer: Estimation of Optimal Duration of Treatment
NCT03789019 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change
NCT05010031 ·Status: RECRUITING ·Phase: PHASE2
-
Patterns of Care and Outcomes in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer
NCT07092254 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Utility of FES F18 PET/CT in Metastatic Breast Cancer Patients
NCT05068726 ·Status: TERMINATED
-
Dasatinib in Combination With Zoledronic Acid for the Treatment of Breast Cancer With Bone Metastasis
NCT00566618 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Lipo-dox and Cyclophosphamide /5-Fluorouracil in Patients With Metastatic Breast Cancer
NCT01451580 ·Status: UNKNOWN ·Phase: PHASE2
-
Merestinib on Bone Metastases in Subjects With Breast Cancer
NCT03292536 ·Status: TERMINATED ·Phase: PHASE1
-
An All-Oral Combination of Capecitabine and Cyclophosphamide in Patients With Metastatic Breast Cancer (MBC)
NCT00589901 ·Status: UNKNOWN ·Phase: PHASE2
-
ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases
NCT02048059 ·Status: COMPLETED ·Phase: PHASE2
-
Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast Cancer
NCT00156273 ·Status: COMPLETED
-
An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)
NCT01615068 ·Status: COMPLETED
-
Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma
NCT00225056 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluation of Survival in Patients With Metastatic Breast Cancer Receiving High-dose Chemotherapy With Autologous Haematopoietic Stem Cell Transplantation
NCT02860585 ·Status: COMPLETED
-
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
NCT03808337 ·Status: RECRUITING ·Phase: PHASE2
-
Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast Cancer
NCT00091832 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Response to Two Schedules of Capecitabine in Patients With Metastatic Breast Cancer
NCT02028494 ·Status: UNKNOWN ·Phase: NA
-
Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases
NCT00098605 ·Status: COMPLETED ·Phase: PHASE2
-
ANG1005 in Leptomeningeal Disease From Breast Cancer
NCT03613181 ·Status: UNKNOWN ·Phase: PHASE3
-
SFX-01 in the Treatment and Evaluation of Metastatic Breast Cancer
NCT02970682 ·Status: COMPLETED ·Phase: PHASE2
-
Combination of Sorafenib and Radiation for Brain Metastases and Primary Brain Tumors
NCT00639262 ·Status: COMPLETED ·Phase: PHASE1